The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
140 jobs Number of planned job losses
Announcement Date
11 January 2017
Employment effect (start)
Foreseen end date
Description
Elanco Animal Products, a factory on Merseyside, has announced the loss of 140 jobs. The company, which is a division of the pharmaceutical company Eil Lilly, mainly manufactures products which treat diseases among farm animals. A spokesperson commented that the decision was taken after reviewing global conditions and was not reflective of the performance of the workforce on Merseyside. The spokesperson also stressed that the company intends to keep the site open. A voluntary redundancy scheme will operate for permanent staff and arrangements with contractors will be reviewed. A statutory 45 day consultation period is expected to conclude in March 2017.
Sources
11 January 2017: Liverpool Echo
Citation
Eurofound (2017), Elanco Animal Health , Internal restructuring in United Kingdom, factsheet number 89781, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/89781.